231 related articles for article (PubMed ID: 28566093)
41. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
[TBL] [Abstract][Full Text] [Related]
42. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
43. Preoperative radio/chemo-radiotherapy in combination with intraoperative radiotherapy for T3-4Nx rectal cancer.
Sadahiro S; Suzuki T; Ishikawa K; Fukasawa M; Saguchi T; Yasuda S; Makuuchi H; Murayama C; Ohizumi Y
Eur J Surg Oncol; 2004 Sep; 30(7):750-8. PubMed ID: 15296989
[TBL] [Abstract][Full Text] [Related]
44. [A case of advanced rectal cancer responding to oral UFT and Leucovorin-based preoperative chemoradiation therapy].
Shibahara K; Hirazuka T; Yamamoto M; Ninomiya M; Mashino K; Fuji K; Ikeda T; Kahno T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1481-3. PubMed ID: 17033242
[TBL] [Abstract][Full Text] [Related]
45. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
Agostini M; Pucciarelli S; Enzo MV; Del Bianco P; Briarava M; Bedin C; Maretto I; Friso ML; Lonardi S; Mescoli C; Toppan P; Urso E; Nitti D
Ann Surg Oncol; 2011 Sep; 18(9):2461-8. PubMed ID: 21416156
[TBL] [Abstract][Full Text] [Related]
46. Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients.
Okabayashi K; Hasegawa H; Ishii Y; Endo T; Ochiai H; Kubota T; Kitagawa Y
Cancer Chemother Pharmacol; 2009 Feb; 63(3):501-7. PubMed ID: 18461329
[TBL] [Abstract][Full Text] [Related]
47. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation.
Calvo FA; Serrano FJ; Diaz-González JA; Gomez-Espi M; Lozano E; Garcia R; de la Mata D; Arranz JA; García-Alfonso P; Pérez-Manga G; Alvarez E
Ann Oncol; 2006 Jul; 17(7):1103-10. PubMed ID: 16670204
[TBL] [Abstract][Full Text] [Related]
48. Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan.
Lee SU; Kim DY; Kim SY; Baek JY; Chang HJ; Kim MJ; Kim TH; Park JW; Oh JH
Radiat Oncol; 2013 Nov; 8():258. PubMed ID: 24188746
[TBL] [Abstract][Full Text] [Related]
49. Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer.
Seong J; Cho JH; Kim NK; Min JS; Suh CO
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):435-9. PubMed ID: 11380231
[TBL] [Abstract][Full Text] [Related]
50. Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.
Maréchal R; Vos B; Polus M; Delaunoit T; Peeters M; Demetter P; Hendlisz A; Demols A; Franchimont D; Verset G; Van Houtte P; Van de Stadt J; Van Laethem JL
Ann Oncol; 2012 Jun; 23(6):1525-30. PubMed ID: 22039087
[TBL] [Abstract][Full Text] [Related]
51. Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy.
Feliu J; Calvilio J; Escribano A; de Castro J; Sánchez ME; Mata A; Espinosa E; García Grande A; Mateo A; González Barón M
Ann Oncol; 2002 May; 13(5):730-6. PubMed ID: 12075741
[TBL] [Abstract][Full Text] [Related]
52. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.
Kitayama J; Yasuda K; Kawai K; Sunami E; Nagawa H
Radiat Oncol; 2010 Jun; 5():47. PubMed ID: 20525293
[TBL] [Abstract][Full Text] [Related]
53. Health-related quality of life of colorectal cancer patients receiving oral UFT plus leucovorin compared with those with surgery alone.
Tsunoda A; Nakao K; Tsunoda Y; Watanabe M; Matsui N
Int J Clin Oncol; 2010 Apr; 15(2):153-60. PubMed ID: 20191299
[TBL] [Abstract][Full Text] [Related]
54. Comparative analysis of preoperative chemoradiotherapy and upfront surgery in the treatment of upper-half rectal cancer: oncological benefits, surgical outcomes, and cost implications.
Wang Y; Wang X; Chen J; Huang S; Huang Y
Updates Surg; 2024 Jun; 76(3):949-962. PubMed ID: 38240957
[TBL] [Abstract][Full Text] [Related]
55. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis.
Ceelen W; Fierens K; Van Nieuwenhove Y; Pattyn P
Int J Cancer; 2009 Jun; 124(12):2966-72. PubMed ID: 19253365
[TBL] [Abstract][Full Text] [Related]
56. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer.
de la Torre A; Ramos S; Valcárcel FJ; Candal A; Regueiro CA; Romero J; Magallón R; Salinas J; de las Heras M; Veiras C; Tisaire JL; Aragón G
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):629-34. PubMed ID: 10524415
[TBL] [Abstract][Full Text] [Related]
57. Oncologic outcomes after radical surgery following preoperative chemoradiotherapy for locally advanced lower rectal cancer: abdominoperineal resection versus sphincter-preserving procedure.
Kim JS; Hur H; Kim NK; Kim YW; Cho SY; Kim JY; Min BS; Ahn JB; Keum KC; Kim H; Sohn SK; Cho CH
Ann Surg Oncol; 2009 May; 16(5):1266-73. PubMed ID: 19224287
[TBL] [Abstract][Full Text] [Related]
58. UFT (tegafur-uracil) in rectal cancer.
Casado E; Pfeiffer P; Feliu J; González-Barón M; Vestermark L; Jensen HA
Ann Oncol; 2008 Aug; 19(8):1371-1378. PubMed ID: 18381370
[TBL] [Abstract][Full Text] [Related]
59. The management of gastric adenocarcinoma with postoperative chemoirradiation. A non-randomized comparison of oral UFT and 5-FU.
Surenkok S; Beyzadeoglu M; Oysul K; Ozyigit G; Ataergin S; Arpaci F; Ozet A
Tumori; 2008; 94(1):70-4. PubMed ID: 18468338
[TBL] [Abstract][Full Text] [Related]
60. Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan.
Yu YL; Tseng WK; Liao CK; Yeh CY; Chen HH; Liu YH; Liaw YW; Fan CW
BMC Cancer; 2023 Sep; 23(1):900. PubMed ID: 37749535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
